[PDF][PDF] Comparison of effectiveness and safety of low-dose versus standard-dose intravenous recombinant tissue plasminogen activator in patients with acute ischemic …
J Karedath, FNU Avanteeka, MN Aslam, A Nadeem… - Cureus, 2023 - cureus.com
The aim of the present meta-analysis is to compare the efficacy and safety of low-dose and
standarddose recombinant tissue plasminogen activators (r-tPA) in patients with acute …
standarddose recombinant tissue plasminogen activators (r-tPA) in patients with acute …
The use of intravenous thrombolytics in acute ischemic stroke management: a scoping review from 2008 till 2021 in the Arab world in the Middle East and North Africa
Objective The aim of this review was to assess and analyze the research output on
intravenous thrombolysis in acute ischemic stroke in the Arab world in the Middle East and …
intravenous thrombolysis in acute ischemic stroke in the Arab world in the Middle East and …
[HTML][HTML] Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis
BH Li, JH Wang, H Wang, DZ Wang, S Yang… - Frontiers in …, 2022 - frontiersin.org
Background This study aims to assess the efficacy and safety of different doses of
intravenous tissue-type plasminogen activator (tPA) for acute ischemic stroke (AIS) by …
intravenous tissue-type plasminogen activator (tPA) for acute ischemic stroke (AIS) by …